Vertex Pharmaceuticals Achieves #48 Analyst Rank, Surpassing HCA Healthcare
July 13, 2020 at 11:46 AM EDT
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Vertex Pharmaceuticals, Inc. (VRTX) has taken over the #48 spot from HCA Healthcare Inc (HCA), according to ETF Channel..
